Quality of Life of Children/Adolescents in Palliative Care Settings (MOSAIK)

August 24, 2020 updated by: University Hospital, Toulouse

Exploring the Quality of Life of Children/Adolescents in Palliative Settings and That of Their Parents

Investigators will propose to each family monitored by the teams to participate in the study (children between 1 and 18 years old, families understanding and speaking a minimum of French).

Semi-directed interviews are organized with children/adolescents and their parents who have agreed to participate in the study. The interviews are conducted by the care teams themselves. Socio-demographic data are collected.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

An information letter will be distributed to the children and parents and their non opposition to their participation will be sought (or assent for the child via a written document adapted to the age) will be systematically requested.

Several instruments will be used by the members of the paediatric teams during their routine home or hospital visits to children and their families: the CPOS (Downing 2018), the KINDL (generic questionnaire on quality of life validated for healthy children, Erhart et al. 2009), the QOLLTI-F v.2 (questionnaire on quality of life for parents, Cohen 2007, 2015).

The interviews will therefore be semi-directed interviews with children/adolescents and their parents who have agreed to participate in the study. The interviews will be conducted by the care teams themselves. In addition to the CPOS, KINDL and QOOLTI-F, socio-demographic data are collected.

Study Type

Observational

Enrollment (Anticipated)

320

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France, 31059
        • Recruiting
        • Agnès SUC
        • Contact:
        • Principal Investigator:
          • Agnès SUC, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Child/parent pair agrees to participate, they give their agreement orally and their non-opposition is documented in the patient's medical record.

Interviews are conducted at home and/or at the hospital depending on where the child is usually cared for by the usual care team.

Description

Inclusion Criteria:

  • Children/adolescents aged 1 to 18 years with a serious illness and requiring follow-up by a regional pediatric palliative care resource team and/or temporarily hospitalized.
  • Having given his non-opposition to his participation.
  • A minor of whom at least one of the two holders of parental authority has given his or her consent to the participation of their child.
  • Child of whom one of the two holders of parental authority has himself agreed to participate in the study.

Exclusion Criteria:

  • Children/adolescents at the end of life (imminent death foreseeable).
  • Children/adolescents and their parents who do not understand French.
  • Child or parent under legal protection (guardianship, curatorship).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Child
Children/adolescents from 1 to 18 years of age with a serious illness requiring follow-up by a regional pediatric palliative care resource team and/or temporarily hospitalized.
semi-structured interviews on the quality of life
Parents
Adult person with parental authority over a child between the ages of 1 and 18 who is a carrier of a serious illness and requires follow-up by a regional pediatric palliative care resource team and/or is temporarily hospitalized.
semi-structured interviews on the quality of life

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life measure
Time Frame: Day 1
Exploring the quality of life of children/adolescents in palliative settings and that of their parents through the development of the Childrens palliative outcome scale.
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
psychometric measure - KINDL
Time Frame: Day 1
using the validated questionnaire KINDL, French version
Day 1
psychometric measure - QOLLTI-F
Time Frame: Day 1
using the the validated questionnaire Quality of life in life threatening illness-family caregiver QOLLTI-F.
Day 1
psychometric measure - Children's palliative outcome scale
Time Frame: Day 1
Documentation of the psychometric properties of the Children's palliative outcome scale
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Agnes SUC, MD, Toulouse University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 15, 2020

Primary Completion (ANTICIPATED)

December 15, 2020

Study Completion (ANTICIPATED)

November 15, 2022

Study Registration Dates

First Submitted

July 29, 2020

First Submitted That Met QC Criteria

August 24, 2020

First Posted (ACTUAL)

August 26, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 26, 2020

Last Update Submitted That Met QC Criteria

August 24, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • RC31/19/0347
  • 2019-A02315-52 (OTHER: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Care

Clinical Trials on Questionnaire

Subscribe